TENS in Post-operative Total Knee Arthroplasty Recovery and Intra-venous Analgesics Requirement
Effects of Transcutaneous Electrical Nerve Stimulation in Post-operative Total Knee Arthroplasty Recovery and Intra-venous Analgesics Requirement
1 other identifier
interventional
60
1 country
1
Brief Summary
Total knee arthroplasty (TKA) is among the major advancements for the treatment of knee pain and improvement of physical function when conservative management fails to comply with. The success of this arthoplasty results in more functional mobility and better quality of life. However, management of pain after TKA in post-operative period is a big challenge to deal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 12, 2022
CompletedStudy Start
First participant enrolled
July 13, 2022
CompletedFirst Posted
Study publicly available on registry
July 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2022
CompletedApril 7, 2023
April 1, 2023
5 months
July 12, 2022
April 5, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pain Intensity
Pain intensity will be measured using Visual Analogue Scale
Pain intensity will be measured at baseline,and change in pain intensity will be measured from baseline to 24 hour, 48 hour and 72 hours.
Rang of Motion
Knee Rang of Motion will be measured using Universal Goniometer
Knee Range of Motion will be measured at baseline, and Change in Knee Range of Motion will be measured from baseline to 24 hour, 48 hour and 72 hours
Intra-venous analgesic requirement
Dose and frequency of intravenous analgesic requirement will be observed through Patient's file
Analgesics requirement will be observed at first post-operative day, at second post-operative day, at third post-operative day
Secondary Outcomes (1)
Length of Hospital Stay
It will be measured from the time of randomization till the time of discharge from hospital upto ten days
Study Arms (2)
Therapeutic Exercise Group
ACTIVE COMPARATORThis group will receive Routine Physical therapy protocol along with prescribed intra-venous regimen.
TENS Plus Therapeutic Exercise Group
EXPERIMENTALThis group will receive high frequency Transcutaneous Electrical Nerve Stimulation with routine physical therapy and prescribed intra-venous regimen.
Interventions
ROM Exercises will be performed and analgesics including the NSAIDs and narcotics as per prescription of surgeon/physician will be given to all subjects
High frequency stimulations via Transcutaneous Electrical Nerve Simulator will be applied. ROM Exercises will be performed and analgesics including the NSAIDs and narcotics as per prescription of surgeon/physician will be given to all subjects
Eligibility Criteria
You may qualify if:
- Both male and female
- Aged between 31-70 years
- Total Knee Arthoplasty, who had been diagnosed with knee osteoarthritis, inflammatory arthritis, trauma, fracture result in total knee arthoplasty.
You may not qualify if:
- Any allergic condition of skin
- Chronic consumption of opioids
- History of dysplasia or malignancy to knee joint
- Any major bone operation of lower limb
- BMI higher than 35 kg m-2
- History of mental disorder
- Neurological illness e.g. Alzheimer which might interfere with assessment process.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Lahore
Lahore, Punjab Province, 54000, Pakistan
Study Officials
- STUDY DIRECTOR
Prof. Dr. Ashfaq Ahmed, PhD
University of Lahore
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor will be unaware of the treatment group
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 12, 2022
First Posted
July 22, 2022
Study Start
July 13, 2022
Primary Completion
December 15, 2022
Study Completion
December 15, 2022
Last Updated
April 7, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Beginning 9 months and ending on 36th month
it will be shared immediately after publication